Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
59 Cards in this Set
- Front
- Back
- 3rd side (hint)
What is the role and leukocyte molecule that P-selectin binds?
|
Sialyl-Lewis X-modified proteins
|
Rolling (neutrophils, monocytes, T lymphocytes)
|
|
What is the role and leukocyte molecule that E-selectin binds?
|
Sialyl-Lewis X-modified proteins
|
Rolling and adhesion (neutrophils, monocytes, T lymphocytes)
|
|
What is the role and leukocyte molecule that GlyCam-1, CD34 binds?
|
L-selectin - L-selectin is expressed weakly on neutrophils. It is involved in the binding of circulating T-lymphocytes to the high endothelial venules in lymph nodes and mucosal lymphoid tissues, and subsequent "homing" of lymphocytes to these tissues.
|
Rolling (neutrophils, monocytes)
|
|
What is the role and leukocyte molecule that ICAM-1 binds?
|
CD11/CD18 (β2) integrins (LFA-1, Mac-1)
|
Adhesion, arrest, transmigration (neutrophils, monocytes, lymphocytes)
|
|
What is the role and leukocyte molecule that VCAM-1 binds?
|
VLA-4 (β1) integrin
|
Adhesion (eosinophils, monocytes, lymphocytes)
|
|
Cells and Molecules Involved in Acute respiratory distress syndrome
|
Neutrophils
|
|
|
Cells and Molecules Involved in Acute transplant rejection
|
Lymphocytes; antibodies and complement
|
|
|
Cells and Molecules Involved in Asthma
|
Eosinophils; IgE antibodies
|
|
|
Cells and Molecules Involved in Glomerulonephritis
|
Neutrophils, monocytes; antibodies and complement
|
|
|
Cells and Molecules Involved in Septic shock
|
Cytokines
|
|
|
Cells and Molecules Involved in Lung abscess
|
Neutrophils (and bacteria)
|
|
|
Cells and Molecules Involved in Arthritis
|
Lymphocytes, macrophages; antibodies?
|
|
|
Cells and Molecules Involved in Chronic Asthma
|
Eosinophils; IgE antibodies
|
|
|
Cells and Molecules Involved in Atherosclerosis
|
Macrophages; lymphocytes?
|
|
|
Cells and Molecules Involved in Chronic transplant rejection
|
Lymphocytes; cytokines
|
|
|
Cells and Molecules Involved in Pulmonary fibrosis
|
Macrophages; fibroblasts
|
|
|
Defect in Leukocyte adhesion deficiency 1
|
Defective leukocyte adhesion because of mutations in β chain of CD11/CD18 integrins
|
|
|
Defect in Leukocyte adhesion deficiency 2
|
Defective leukocyte adhesion because of mutations in fucosyl transferase required for synthesis of sialylated oligosaccharide (ligand for selectins)
|
|
|
Defect in Chronic granulomatous disease
|
Decreased oxidative burst
|
|
|
Defect in MPO deficiency
|
Decreased microbial killing because of defective MPO-H2O2 system
|
|
|
Defect in Chédiak-Higashi syndrome
|
Decreased leukocyte functions because of mutations affecting protein involved in lysosomal membrane traffic
|
|
|
Defect in Bone marrow suppression: tumors, radiation, and chemotherapy
|
Production of leukocytes
|
|
|
Defect in Diabetes, malignancy, sepsis, chronic dialysis
|
Adhesion and chemotaxis
|
|
|
Defect in Leukemia, anemia, sepsis, diabetes, malnutrition
|
Phagocytosis and microbicidal activity
|
|
|
What is the principal source and action of histamine
|
Mast cells, basophils, platelets
|
Vasodilation, increased vascular permeability, endothelial activation
|
|
What is the principal source and action of serotonin
|
Platelets
|
Vasodilation, increased vascular permeability
|
|
What is the principal source and action of prostaglandins
|
Mast cells, leukocytes
|
Vasodilation, pain, fever
|
|
What is the principal source and action of leukotrienes
|
Mast cells, leukocytes
|
Increased vascular permeability, chemotaxis, leukocyte adhesion and activation
|
|
What is the principal source and action of PAF (platelet-activating factor)
|
Leukocytes, mast cells
|
Vasodilation, increased vascular permeability, leukocyte adhesion, chemotaxis, degranulation, oxidative burst
|
|
What is the principal source and action of ROS
|
Leukocytes
|
Killing of microbes, tissue damage
|
|
What is the principal source and action of NO
|
Endothelium, macrophages
|
Vascular smooth muscle relaxation, killing of microbes
|
|
What is the principal source and action of cytokines (TNF, IL-1)
|
Macrophages, endothelial cells, mast cells
|
Local endothelial activation (expression of adhesion molecules), fever/pain/anorexia/hypotension, decreased vascular resistance (shock)
|
|
What is the principal source and action of chemokines
|
Leukocytes, activated macrophages
|
Chemotaxis, leukocyte activation
|
|
What is the principal source and action of complement products (C5a, C3a, C4a)
|
Plasma (produced in liver)
|
Leukocyte chemotaxis and activation, vasodilation (mast cell stimulation)
|
|
What is the principal source and action of Kinins
|
Plasma (produced in liver)
|
Increased vascular permeability, smooth muscle contraction, vasodilation, pain
|
|
What is the principal source and action of proteases activated during coagulation
|
Plasma (produced in liver)
|
Endothelial activation, leukocyte recruitment
|
|
Principal action of PGI2 (prostacyclin), PGE1, PGE2, PGD2
|
Vasodilation
|
|
|
Principal action of Thromboxane A2, leukotrienes C4, D4, E4
|
Vasoconstriction
|
|
|
Principal action of Leukotrienes C4, D4, E4
|
Increased vascular permeability
|
|
|
Principal action of Leukotriene B4, HETE
|
Chemotaxis, leukocyte adhesion
|
|
|
Principal source and action of TNF
|
Macrophages, mast cells, T lymphocytes
|
Stimulates expression of endothelial adhesion molecules and secretion of other cytokines; systemic effects
|
|
Principal source and action of IL-1
|
Macrophages, endothelial cells, some epithelial cells
|
Similar to TNF; greater role in fever
|
|
Principal source and action of IL-6
|
Macrophages, other cells
|
Systemic effects (acute-phase response)
|
|
Principal source and action of chemokines
|
Macrophages, endothelial cells, T lymphocytes, mast cells, other cell types
|
Recruitment of leukocytes to sites of inflammation; migration of cells to normal tissues
|
|
Principal source and action of IL-12
|
Dendritic cells, macrophages
|
Increased production of IFN-γ
|
|
Principal source and action of IFN-γ
|
T lymphocytes, NK cells
|
Activation of macrophages (increased ability to kill microbes and tumor cells)
|
|
Principal source and action of IL-17
|
T lymphocytes
|
Recruitment of neutrophils and monocytes
|
|
What are the mediators of Vasodilation
|
Prostaglandins
Nitric oxide Histamine |
|
|
What are the mediators of Increased vascular permeability
|
Histamine and serotonin
C3a and C5a (by liberating vasoactive amines from mast cells, other cells) Bradykinin Leukotrienes C4, D4, E4 PAF Substance P |
|
|
What are the mediators of Chemotaxis, leukocyte recruitment and activation
|
TNF, IL-1
Chemokines C3a, C5a Leukotriene B4 (Bacterial products, e.g., N-formyl methyl peptides) |
|
|
What are the mediators of fever
|
IL-1, TNF
Prostaglandins |
|
|
What are the mediators of pain
|
Prostaglandins
Bradykinin |
|
|
What are the mediators of tissue damage
|
Lysosomal enzymes of leukocytes
Reactive oxygen species Nitric oxide |
|
|
Cause and tissue reaction of tuberculosis
|
Mycobacterium tuberculosis
|
Caseating granuloma (tubercle): focus of activated macrophages (epithelioid cells), rimmed by fibroblasts, lymphocytes, histiocytes, occasional Langhans giant cells; central necrosis with amorphous granular debris; acid-fast bacilli
|
|
Cause and tissue reaction of leprosy
|
Mycobacterium leprae
|
Acid-fast bacilli in macrophages; noncaseating granulomas
|
|
Cause and tissue reaction of syphilis
|
Treponema pallidum
|
Gumma: microscopic to grossly visible lesion, enclosing wall of histiocytes; plasma cell infiltrate; central cells necrotic without loss of cellular outline
|
|
Cause and tissue reaction of cat-scratch disease
|
Gram-negative bacillus
|
Rounded or stellate granuloma containing central granular debris and recognizable neutrophils; giant cells uncommon
|
|
Cause and tissue reaction of sarcoidosis
|
Unknown etiology
|
Noncaseating granulomas with abundant activated macrophages
|
|
Cause and tissue reaction of Crohn disease (inflammatory bowel disease)
|
Immune reaction against intestinal bacteria, self-antigens
|
Occasional noncaseating granulomas in the wall of the intestine, with dense chronic inflammatory infiltrate
|